| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Lennon David James is a Chief Executive Officer at Whitehawk Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sell | 14,500 | $3.38 | $49,010.00 | -2.7% | - | - | |
| Apr 8, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sell | 260,427 | $3.45 | $899,537.86 | -12.5% | - | - | |
| Mar 3, 2025 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,690 | $2.35 | $13,371.50 | -14.5% | -24.3% | +44.3% | |
| Oct 3, 2024 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 9,689 | $1.94 | $18,796.66 | -29.8% | +63.5% | +2.1% |